HOME >> MEDICINE >> NEWS
Are UK consent rules too restrictive?

Regulations on the use of human tissue in the United Kingdom are now more restrictive than any other European country. Is the UK leading the way or overreacting to recent publicity about inadequate consent procedures?

The new regulations require explicit consent from every patient. Explicit consent is appropriate for the use of emotionally important samples such as post-mortem tissue, but the new regulations also apply to all samples from living patients, including resected tumours, tiny biopsies, even blood and urine.

Although this takes due account of the autonomy of the few who object, it is now inhibiting work done for the good of everyone and has other ethically undesirable consequences, says Professor Peter Furness, in this week's BMJ.

Recording the wishes of all patients whenever samples are taken would resolve this problem but this has major resource implications, he writes. So is implied consent - asking the few who object to make their wishes known a reasonable possibility for the use of tissue from living patients for research?

Implied consent was recommended by the Nuffield Council on Bioethics in 1995, but has since been rejected by the Medical Research Council, despite evidence that patients thought it was appropriate. The Department of Health for England has so far taken a similar line to the MRC.

"If we are serious about empowering patients to control the use of their tissue samples, resources must be allocated irrespective of whether implied or explicit consent is regarded as appropriate," says the author. "Without such resources our laboratories are forced into paralysis or continuing paternalism. At present we have both."


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
2-Oct-2003


Page: 1

Related medicine news :

1. Obtaining patient consent for clinical audit is unworkable without extra resources
2. Improving informed consent for children in cancer treatment studies
3. Discussion plus pamphlet better than just discussion for informed consent
4. Informed consent does not seem to influence decision-making process for cataract surgery
5. Early use of universal forms boosts informed consent among ICU patients
6. New approach required for obtaining informed consent in less-developed countries
7. People are unlikely to withdraw consent for genetic research
8. New consent rules may threaten our health
9. Audiovisual recording of oral consent for illiterate populations (p 1406)
10. Researchers recommend community advisory boards to prevent lapses in informed consent
11. New study provides mixed report card on informed consent to cancer clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Are consent rules too restrictive

(Date:10/22/2014)... (PRWEB) October 22, 2014 For Dr. Iris ... make money; it’s an extension of her life’s mission. Her ... venture as the owner of FirstLight HomeCare, make it clear ... important to me that my work makes a difference in ... an entrepreneurial spirit, so after much research, I felt ready ...
(Date:10/22/2014)... 22, 2014 The Louis ... is dedicated to distribute health information technology innovation ... worldwide announced the development of six key guiding ... when receiving healthcare. These are an expansion of ... “providing care that is respectful of and responsive ...
(Date:10/22/2014)... 22, 2014 Best Cheap Hosting USA ... world. The site has recently announced that iPower ( ... for people from around the world. , “iPower is ... today and is providing various kinds of useful products ... insists on offering excellent customer service and a number ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, ... Sales, will be speaking on the subject of “Event ... October 28, at the Holiday Inn in New York ... well as a Tech Demo at 12:45pm, to educate ... more engaging event experience. , The Annual Meetings Technology ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter , ... in vitro fertilization (IVF) are only about half as likely ... reproduction technique, new research indicates, and the racial disparity persists ... about 31 percent of white patients became pregnant after IVF, ... more than 4,000 IVF cycles over two years to tease ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3
(Date:10/22/2014)... 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) ... novel investigational drug for cancer, is designed for injection ... effects. Its oncology focus is on melanoma, breast cancer ... 2 trials of PV-10 as a therapy for metastatic ... atopic dermatitis and psoriasis. This summer, ...
(Date:10/22/2014)... , Oct. 22, 2014  Recently published clinical ... bolstered the already substantial database of evidence. This data ... of Stretta therapy for sufferers of refractory ... clinical evidence supporting Stretta therapy as a safe ... that make Stretta therapy available to nearly 50 million ...
(Date:10/22/2014)... and SHANGHAI , Oct. 22, 2014 ... FMI ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... offer Foundation Medicine,s comprehensive genomic profiling to biopharmaceutical companies ... Under the terms of the collaboration, ... the laboratory component of Foundation Medicine,s FoundationOne® assay at ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5
Cached News: